X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

International Immunopharmacology

期刊標題檢索 INT IMMUNOPHARM 最新評論: After two and a half months of submission, it was rejected because the... (2025-09-08)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[International Immunopharmacology]您好,您是該頁面的第 503114 位訪客。

期刊簡介
期刊名稱International Immunopharmacology International Immunopharmacology
LetPub Score
7.4
50 ratings
Rate

Reputation
8.0

Influence
6.6

Speed
8.8

期刊簡稱INT IMMUNOPHARMACOL
ISSN1567-5769
E-ISSN1878-1705
h-index98
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.201.2390.980
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q180 / 321
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Immunology and Allergy
Q267 / 231
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Immunology
Q280 / 240

自引率 (2023-2024)4.20%自引率趨勢
掲載範囲
International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.

The subject material appropriate for submission includes:
• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.
• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.
• Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.
• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.
• Agents that activate genes or modify transcription and translation within the immune response.
• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.
• Production, function and regulation of cytokines and their receptors.
• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.
官方網站https://www.journals.elsevier.com/international-immunopharmacology
在線稿件提交https://www.editorialmanager.com/INTIMP
開放訪問No
出版商Elsevier
主題領域医学
出版國/地區NETHERLANDS
發行頻率月刊
創刊年2001
每年文章數2156每年文章數趨勢
黃金OA百分比17.64%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ250/183
PHARMACOLOGY & PHARMACYSCIEQ154/352
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1567-5769%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 2.7 month(s)
來自Elsevier的數據: Average 7.5 Week(s)
競爭力 *來自作者的數據: About 81.66%
在線文章發布時間來自Elsevier的數據: Average 2.7 Week(s)
參考鏈接
相關期刊 【International Immunopharmacology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 84.70
    NATURE IMMUNOLOGYH-index: 344

    CiteScore: 38.20
    Annual Review of ImmunologyH-index: 279

    CiteScore: 55.50
    ImmunityH-index: 355

    CiteScore: 40.80
    Cellular & Molecular ImmunologyH-index: 64

    CiteScore: 36.20
    TRENDS IN IMMUNOLOGYH-index: 209

    CiteScore: 21.20
    JOURNAL OF EXPERIMENTAL MEDICINEH-index: 411

    CiteScore: 22.10
    AUTOIMMUNITY REVIEWSH-index: 103

    CiteScore: 16.80
    BRAIN BEHAVIOR AND IMMUNITYH-index: 127

    CiteScore: 15.20
    Mucosal ImmunologyH-index: 82

    CiteScore: 16.50
    學科內最受檢索的期刊 頁面查看次數
    JOURNAL OF IMMUNOLOGY159676
    MOLECULAR IMMUNOLOGY113897
    Immunity111343
    Cellular & Molecular Immunology111244
    IMMUNOLOGY110798
    MEDIATORS OF INFLAMMATION108883
    Vaccine107708
    MICROBIAL PATHOGENESIS107332
    JOURNAL OF EXPERIMENTAL MEDICINE105264
    INFLAMMATION100263
  •  

    International Immunopharmacology International Immunopharmacology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/60)
  [International Immunopharmacology] 的評論撰寫評論
作者: ssssss123


領域: 医学
審稿時間: 3.0 month(s)
結果: 拒稿


撰寫評論

2025-09-08 09:05:56 評論於
After two and a half months of submission, it was rejected because they couldn't find a reviewer.
(0) 讚! | ssssss123

作者: yes11996


領域: 医学
審稿時間: 3.0 month(s)
結果: 待定&不明


撰寫評論

2025-09-04 14:20:30 評論於
It's not fast. Either we can't find the reviewer for rework, or they accept it without reviewing it, even minor revisions are sent for external review. It's driving me crazy.
(0) 讚! | yes11996

作者: zhengyi8304


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2025-09-03 21:05:04 評論於
Similarly, it has been a month since the new editor took over. In the past, this magazine was known for its fast pace, but this time, the feedback and reviews seem to be different from before.
(0) 讚! | zhengyi8304

作者: 佐心迩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-21 12:02:12 評論於
It has been almost a month since the second review was sent back. One reviewer has been ignoring it and not reviewing it. Anxious...
(0) 讚! | 佐心迩

作者: yes11996


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-21 05:40:50 評論於
It's been almost a month since the second review was sent back. There is a reviewer who has been ignoring the review. It's so urgent.
(0) 讚! | yes11996

作者: 施景龙 SHI


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-13 12:33:29 評論於
I also want to ask how often it will be updated, as I have been editing it continuously.
(0) 讚! | 施景龙 SHI

作者: 施景龙 SHI


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-13 12:25:08 評論於
How long did it take to make the first decision?
(0) 讚! | 施景龙 SHI

作者: 施景龙 SHI


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-13 11:50:45 評論於
Is it a commissioned review?
(0) 讚! | 施景龙 SHI

作者: liunian xie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-06 06:52:40 評論於
Is it normal for the review process to take so long? It has been 5 days and I am still "with editor".
(0) 讚! | liunian xie

作者: 刘娇娇


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-07-10 10:37:03 評論於
Hello, my days have been with the editor recently, it seems like it's a technical review.
(0) 讚! | 刘娇娇

作者: 刘娇娇


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-07-10 10:23:04 評論於
How long until it is submitted for review later?
(0) 讚! | 刘娇娇

作者: 刘娇娇


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-07-10 10:22:03 評論於
How long will it take to submit for review later?
(0) 讚! | 刘娇娇

作者: smart宋


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2025-07-03 16:02:45 評論於
4.11 Submission
6.21 Review comments received, a total of two reviewers, with 17 comments.
6.30 Revision
7.3 Acceptance.
(0) 讚! | smart宋

作者: 是宝宝吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-07-02 11:47:23 評論於
Do you still accept bibliometrics?
(0) 讚! | 是宝宝吖

作者: grinning


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-06-10 08:58:14 評論於
Could you please tell me how to view the specific process? On which day did the reviewer accept the invitation? On which day did they complete the review?
(0) 讚! | grinning

作者: 晚风吻尽荷花叶


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2025-05-30 18:02:07 評論於
Half an hour ago, I was hired. Let me update the timeline:
4.15 Third reviewer accepted the review.
4.27 Comments from the third reviewer returned, and both reviewers completed the review, automatically leading to RRC.
4.28 Editor requested major revisions.
5.3 Revised manuscript submitted for second review.
5.4 Submitted for review.
5.13 RRC.
5.15 Editor requested major revisions.
5.20 Revised manuscript submitted for third review, sent for review the same day.
5.29 RRC.
5.30 Accept.

The first reviewer was obviously an AI reviewer, and their comments were quite silly. However, they were kind and had a bias in their opinions.
The second reviewer was very sharp, hitting the main points directly, and even mentioned concerns about the scientific rigor of the article. I am not sure if it will require major revisions, I even thought they might recommend rejection in the first review. But it seems like in this journal, major revisions + rejection = rejection, so it is likely to be major revisions.

For the second review, I was quite casual in addressing the comments from the first reviewer, but they still said I addressed all their concerns...haha, what a lenient reviewer.
In the second review, the second reviewer still found some errors in my manuscript. This person indeed paid attention to detail.

After 8 days of revisions for the third review, the second reviewer also accepted it. I thought this person might have some negative comments again, and it almost scared me to death.
(0) 讚! | 晚风吻尽荷花叶

作者: Wang jingtao


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-05-22 12:45:55 評論於
I am also in this state, what state are you in now?
(0) 讚! | Wang jingtao

作者: 冰凌忍冬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-05-16 10:10:20 評論於
Oh my goodness, I don't need external validation.
(0) 讚! | 冰凌忍冬

作者: 冰凌忍冬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-05-16 10:09:17 評論於
It shouldn't be, right?
(0) 讚! | 冰凌忍冬

作者: 冰凌忍冬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-05-16 10:05:39 評論於
How is everything going?
(0) 讚! | 冰凌忍冬

作者: 冰凌忍冬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-05-16 09:33:52 評論於
I also want to ask how long it will take for changes to be made after "with editor", and when can I be notified.
(0) 讚! | 冰凌忍冬

作者: 晚风吻尽荷花叶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-04-25 20:47:32 評論於
3.13 submitted for review
3.13 invited 6 reviewers
The first reviewer accepted the invitation on 3.13
The first reviewer completed the review on 3.15 (accepted the invitation on the same day, completed the review in 2 days, this reviewer is super fast)
The second reviewer accepted the invitation on 3.15
4.10 added 4 more invitations (a total of 10 reviewers invited) because the editor thought the second reviewer had disappeared
The third reviewer accepted the invitation on 4.15
(0) 讚! | 晚风吻尽荷花叶

作者: 北方大虾


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2025-04-12 18:59:14 評論於
After submitting my paper, I was rejected with comments, feeling frustrated. The main issue was with the writing of the paper. I wanted to ask if I need to change the title of the paper before resubmitting it? Is the problem of duplicate paper titles preventing submission?
(0) 讚! | 北方大虾

作者: 我懒


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2025-03-28 22:03:58 評論於
After I went back for rework, my speed was not as fast as the first review. Have you got any results?
(0) 讚! | 我懒

作者: 小卖铺老板


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-03-20 12:23:41 評論於
Please translate the following paragraph into English: "Shabi Chinese Academy of Sciences."
(0) 讚! | 小卖铺老板

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/60)

開始撰寫 [International Immunopharmacology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*